Phase 4 Rheumatoid arthritis trials recruiting now

All Rheumatoid arthritis trials, every phase

Other phases for Rheumatoid arthritis

Phase 4 Rheumatoid arthritis trials

• Advanced Therapeutics in Rheumatoid Arthritis (RA)
  NCT03976245 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Belimumab After Rituximab in Resistant Primary Juvenile SS
  NCT06410833 · Phase: Phase 4 · Ages: 5 Years to 18 Years · Sex: All (male and female) · 1 location
• Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)
  NCT04985435 · Phase: Phase 4 · Ages: 18 Years to 101 Years · Sex: All (male and female) · 1 location
• Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
  NCT07611747 · Phase: Phase 4 · Ages: 50 Years and older · Sex: All (male and female) · 34 locations
• Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)
  NCT06913907 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide
  NCT02714634 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study
  NCT06528431 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors
  NCT07802678 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Effect of JAK Inhibitor on Erosion Healing in RA
  NCT05955066 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis
  NCT06906549 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis
  NCT07721142 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• JAK Inhibitor Dose TAPering Strategy Study
  NCT06687551 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 24 locations
• Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL
  NCT07554820 · Phase: Phase 4 · Ages: 50 Years to 85 Years · Sex: All (male and female) · 1 location
• MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active Rheumatoid Arthritis
  NCT06649136 · Phase: Phase 4 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares
  NCT07245732 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis
  NCT05540938 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
  NCT07160231 · Phase: Phase 4 · Ages: 16 Years and older · Sex: All (male and female) · 14 locations
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
  NCT07087912 · Phase: Phase 4 · Ages: 12 Years to 59 Years · Sex: All (male and female) · 4 locations
• TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE
  NCT07153276 · Phase: Phase 4 · Ages: 30 Years to 65 Years · Sex: Female · 1 location
• Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis
  NCT06003283 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• The Clinical Efficacy of Immunomodulators in RA Patients
  NCT05626348 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
  NCT04981145 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.